HELT and osteosarcoma: The mechanism of action of MGN has been studied, either individually or in combination with other cytostatics, in several malignant types, including gastric [9], breast (MGN+doxorubicin (DOX)) [8] or osteosarcoma (MGN+cisplatin (CDDP)) [33].